Live news related to MEDINCELL stock (FR0004065605): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on MEDINCELL mainly cover M&A activity, analyst notes et share price moves. The stock trades at €26,18 on Euronext Paris, down 0,30% at the last update. This page lists the articles published on MEDINCELL stock to track the share price, company announcements and any item likely to influence market perception.
The Montpellier-based biopharmaceutical company is declining mid-session, in a Paris market also oriented downwards. The share nevertheless remains be…
The Montpellier-based biopharmaceutical company is giving back part of the previous day's rebound, despite a well-oriented Paris market. The stock rem…
The Montpellier-based biopharmaceutical company is recovering ground in mid-afternoon, while its benchmark index declines. The stock rebounds on Tuesd…
In a press release published on October 13, 2026, Medincell announced the receipt of a new €13.8 million loan from European commercial banks and Bpifr…
The Montpellier-based biopharmaceutical company is losing momentum on Tuesday, following an initial decline, after the surge triggered by the U.S. gre…
The Montpellier-based biopharmaceutical company is marking a clear pause this Monday, after the rally triggered Friday by FDA approval. The decline oc…
The Montpellier-based biopharmaceutical company posts the strongest gain in its index, in a well-oriented Paris market. The surge occurs after trading…
American partner Teva Pharmaceuticals has received approval from the U.S. Food and Drug Administration for a monthly injectable formulation of olanzap…
Shares of the Montpellier-based biopharmaceutical company (code MEDCL) have not been traded since market opening at 9:00 AM (CEST) on October 9, 2026.…
The Montpellier-based biopharmaceutical company is catching its breath after several sessions of rebound, in a Paris market oriented downward. The dec…
